These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35666752)

  • 1. The Anterior Eye Chamber as a Visible Medium for In Vivo Tumorigenicity Tests.
    Inagaki E; Arai E; Hatou S; Sayano T; Taniguchi H; Negishi K; Kanai Y; Sato Y; Okano H; Tsubota K; Shimmura S
    Stem Cells Transl Med; 2022 Aug; 11(8):841-849. PubMed ID: 35666752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders.
    Bedel A; Beliveau F; Lamrissi-Garcia I; Rousseau B; Moranvillier I; Rucheton B; Guyonnet-Dupérat V; Cardinaud B; de Verneuil H; Moreau-Gaudry F; Dabernat S
    Stem Cells Transl Med; 2017 Feb; 6(2):382-393. PubMed ID: 28191782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The propensity for tumorigenesis in human induced pluripotent stem cells is related with genomic instability.
    Liang Y; Zhang H; Feng QS; Cai MB; Deng W; Qin D; Yun JP; Tsao GS; Kang T; Esteban MA; Pei D; Zeng YX
    Chin J Cancer; 2013 Apr; 32(4):205-12. PubMed ID: 22704487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicology and carcinogenesis studies of diethylamine (CAS No. 109-89-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2011 Oct; (566):1-174. PubMed ID: 22127322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of a novel xeno-free culture medium for human-induced pluripotent stem cells.
    Hua Y; Yoshimochi K; Li J; Takekita K; Shimotsuma M; Li L; Qu X; Zhang J; Sawa Y; Liu L; Miyagawa S
    Stem Cell Res Ther; 2022 Jun; 13(1):223. PubMed ID: 35658933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transplantation of corneal endothelial cells].
    Amano S
    Nippon Ganka Gakkai Zasshi; 2002 Dec; 106(12):805-35; discussion 836. PubMed ID: 12610838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaline cartilage formation and tumorigenesis of implanted tissues derived from human induced pluripotent stem cells.
    Saito T; Yano F; Mori D; Kawata M; Hoshi K; Takato T; Masaki H; Otsu M; Eto K; Nakauchi H; Chung UI; Tanaka S
    Biomed Res; 2015; 36(3):179-86. PubMed ID: 26106047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells.
    Kuroda T; Yasuda S; Kusakawa S; Hirata N; Kanda Y; Suzuki K; Takahashi M; Nishikawa S; Kawamata S; Sato Y
    PLoS One; 2012; 7(5):e37342. PubMed ID: 22615985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas.
    Kamada M; Mitsui Y; Matsuo T; Takahashi T
    Hum Cell; 2016 Jan; 29(1):1-9. PubMed ID: 26069211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.
    Hayashi Y; Chan T; Warashina M; Fukuda M; Ariizumi T; Okabayashi K; Takayama N; Otsu M; Eto K; Furue MK; Michiue T; Ohnuma K; Nakauchi H; Asashima M
    PLoS One; 2010 Nov; 5(11):e14099. PubMed ID: 21124894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro tumorigenicity tests for process control of health care products derived from human induced pluripotent stem cells].
    Sato Y
    Yakugaku Zasshi; 2013; 133(12):1381-8. PubMed ID: 24292187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transplanted vascular endothelial cells to replace corneal endothelial cells by improved anterior chamber injection].
    Zhu Q; Hu Z; Sun X; Hu M; Liu H; Yang Z
    Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):277-84. PubMed ID: 24931154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo tissue engineering chamber supports human induced pluripotent stem cell survival and rapid differentiation.
    Lim SY; Lee DG; Sivakumaran P; Crombie D; Slavin J; Dottori M; Conley B; Denham M; Leung J; Tee R; Dusting GJ; Pebay A; Dilley RJ
    Biochem Biophys Res Commun; 2012 May; 422(1):75-9. PubMed ID: 22560904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration.
    Kanemura H; Go MJ; Shikamura M; Nishishita N; Sakai N; Kamao H; Mandai M; Morinaga C; Takahashi M; Kawamata S
    PLoS One; 2014; 9(1):e85336. PubMed ID: 24454843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application.
    Ito E; Miyagawa S; Takeda M; Kawamura A; Harada A; Iseoka H; Yajima S; Sougawa N; Mochizuki-Oda N; Yasuda S; Sato Y; Sawa Y
    Sci Rep; 2019 Feb; 9(1):1881. PubMed ID: 30760836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Capacity for differentiation and normalization of populations of tumor cells transplanted into the anterior chamber of the eye. I. Changes in the pleomorphic rhabdomyosarcomas MKh-III and A-7 of mice].
    Al-Rubey AK; Chernakova AV; Pinchuk VG; Shvemberger IN
    Tsitologiia; 1983 Apr; 25(4):458-65. PubMed ID: 6879716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays.
    Bouma MJ; van Iterson M; Janssen B; Mummery CL; Salvatori DCF; Freund C
    Stem Cell Reports; 2017 May; 8(5):1340-1353. PubMed ID: 28494940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of tissue grafts into the anterior eye chamber: a method to study intrinsic neurons.
    Adeghate E; Donáth T
    Brain Res Brain Res Protoc; 2000 Nov; 6(1-2):33-9. PubMed ID: 11086261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotency and oncogenic transformation are related processes.
    Riggs JW; Barrilleaux BL; Varlakhanova N; Bush KM; Chan V; Knoepfler PS
    Stem Cells Dev; 2013 Jan; 22(1):37-50. PubMed ID: 22998387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumorigenic risk of human induced pluripotent stem cell explants cultured on mouse SNL76/7 feeder cells.
    Kamada M; Mitsui Y; Kumazaki T; Kawahara Y; Matsuo T; Takahashi T
    Biochem Biophys Res Commun; 2014 Oct; 453(3):668-73. PubMed ID: 25305485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.